| Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022) |
|---|
| 06/09/2005 | WO2005052542A2 Method and composition useful for determining fk 506 |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
| 05/26/2005 | US20050112778 Method and composition useful for determining FK 506 |
| 05/19/2005 | WO2005018545A3 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/10/2005 | US6890919 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 05/03/2005 | US6887994 C-nitroso compounds and use thereof |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/16/2005 | EP1513518A1 Use of nefopam for the treatment of nausea or emesis |
| 03/16/2005 | EP1513517A1 Formulation of nefopam and its use in the treatment of pain |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/15/2005 | US6867204 Benzoxazine derivatives and uses thereof |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2005018545A2 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/03/2005 | CA2535337A1 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/17/2005 | WO2004080391A3 Novel antibacterial agents |
| 02/17/2005 | CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/16/2005 | EP1506179A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 02/10/2005 | CA2534464A1 Benzoxazepine compound |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/08/2005 | US6852713 Lactam derivatives and methods of their use |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 01/26/2005 | EP0920423B1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 12/21/2004 | US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 12/15/2004 | EP1226122B1 Bicyclic vasopressin agonists |
| 12/08/2004 | EP1482957A1 Antibiotic conjugates |
| 12/08/2004 | CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 12/01/2004 | EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 11/25/2004 | WO2004100958A1 2, 3, 4, 5-tetrahydrobenzo[f][1, 4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer’s disease |
| 11/25/2004 | US20040235819 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease. |
| 11/16/2004 | US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 11/10/2004 | EP1475373A1 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists |
| 11/10/2004 | EP1474404A2 Method for extracting a macrolide from biomatter |
| 11/04/2004 | WO2004093796A2 Lactam derivatives and methods of their use |
| 11/04/2004 | WO2003077847A3 Substituted amides |
| 10/28/2004 | WO2004091628A1 Receptor antagonist |
| 10/27/2004 | EP1471060A1 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/21/2004 | US20040209857 Pharmaceutical compositions containing the compounds and methods for their use are also disclosed. Binding opioid receptors to treat a condition or disease selected from the group consisting of: gastrointestinal dysfunction, ileus, |
| 10/21/2004 | US20040209846 Heterocyclic analgesic compounds and methods of use thereof |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/14/2004 | US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction |
| 10/07/2004 | US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/23/2004 | WO2004080391A2 Novel antibacterial agents |
| 09/23/2004 | CA2801100A1 Novel antibacterial agents |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 08/17/2004 | US6777550 N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/05/2004 | WO2004064865A1 Skeletal muscle protecting agent |
| 08/05/2004 | CA2513170A1 Skeletal muscle protecting agent |
| 07/08/2004 | WO2004056788A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/08/2004 | WO2004056182A1 Pesticidal dibenzo(hetero)azepine derivatives |
| 07/08/2004 | CA2503172A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 06/16/2004 | EP1304326A4 Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
| 06/16/2004 | EP0973730B1 Calcilytic compounds |
| 06/10/2004 | US20040110742 Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/12/2004 | EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 04/22/2004 | WO2004033437A1 Dibenzoxazepine |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | CA2498658A1 Dibenzoxazepine |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders |
| 04/15/2004 | US20040072819 Benzoxazepine compounds, their production and use |
| 04/14/2004 | EP1407782A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 04/14/2004 | EP1406881A1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | US20040063750 Such as N-propanesulfonyl-((3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl) acetamide which has squalene synthase inhibitory activity |
| 03/31/2004 | EP1403258A1 Dihydrodiaryloxazepine derivative and medicinal composition containing the derivative |
| 03/25/2004 | US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | DE10242488A1 New N-alkyl-dibenzoxazepinone derivatives, are aminopeptidase N inhibitors useful for treating cardiovascular, inflammatory, autoimmune or cancer diseases or chronic pain, especially arteriosclerosis |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |